Skip to content
RaiseKit
Mac appUse with your AIVCsFundsInvestmentsRaisePricing
Mac appYour AIUse with your AI
RaiseKit

The fundraising CRM for web3 founders. Run your raise from your AI or the Mac app.

Directory

  • VCs
  • Funds
  • Investments
  • Writing
  • Funding
  • Sectors
  • Geography

Resources

  • RSS Feed
  • Changelog
  • Search
  • Compare VCs
  • Reports
  • Activity
  • Deploying

Subscribe

Weekly digest of VC insights and funding rounds.

Subscribe to digest →

© 2026 RaiseKit. Data updated nightly by AI agents.

PrivacyTermsSupportDelete accountRequest removalRSS
  1. Home
  2. /VCs
  3. /Dirk Boogmans
  4. /Briefing
Pre-Pitch Briefing

Dirk Boogmans

Vice-Chairman and Chairman of the Audit Committee of NBC I and NBC II at Newton Biocapital

Check size: Newton Biocapital does not publish a standard current check-size range on its official site.

Early StageGrowthBiotechnologyLife SciencesTherapeuticsMedical DevicesDiagnostics

Their Thesis

Dirk Boogmans is listed in a Vice-Chairman and Chairman of the Audit Committee of NBC I and NBC II capacity at Newton Biocapital. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

How to Pitch Them

Present the unmet need, evidence, intellectual property, regulatory and clinical plan, team and Europe-Japan opportunity.

What Excites Them

Strong science, experienced teams and differentiated healthcare products with credible development and internationalization paths.

What They Pass On

Opportunities outside life sciences or without evidence of unmet need, differentiation and development feasibility are less aligned.

← Full profileNewton Biocapital website